In large medical centers, the availability of radiosurgery has relegat
ed brachytherapy to a lesser role in the treatment of newly diagnosed
solitary brain metastases. However, the treatment planning in radiosur
gery is complex, and in some case the hardware is prohibitively expens
ive; low or high dose rate brachytherapy requires only a stereotactic
frame, commercially available software, and encapsulated radionuclides
or newer tiny linear accelerators. Interstitial brachytherapy also re
mains an option for the treatment of recurrent solitary metastases whe
n other forms of treatment have failed. This article reviews the radio
biology of low and high dose rate interstitial brachytherapy, the Univ
ersity of California San Francisco (UCSF) results using iodine-125 imp
lants, and early experience with the photon radiosurgery system (PRS)
at Massachusetts General Hospital for the treatment of brain metastase
s.